Minimal Residual Disease In Hematologic Malignancies

Minimal Residual Disease In Hematologic Malignancies Book in PDF, ePub and Kindle version is available to download in english. Read online anytime anywhere directly from your device. Click on the download button below to get a free pdf file of Minimal Residual Disease In Hematologic Malignancies book. This book definitely worth reading, it is an incredibly well-written.

Minimal Residual Disease in Hematologic Malignancies

Author : Raanani P Ed
Publisher : S. Karger AG (Switzerland)
Page : 0 pages
File Size : 41,8 Mb
Release : 2004
Category : Blood
ISBN : 3805577737

Get Book

Minimal Residual Disease in Hematologic Malignancies by Raanani P Ed Pdf

Detection of minimal residual disease (MRD) is increasingly used in the management of leukemia patients. A wide variety of methods have been developed and include technologies designed to detect residual malignant cells beyond the sensitivity of conventional approaches such as morphology and banding cytogenetics in leukemia. The choice of the best method depends on the biology of the individual malignancy, i.e. on the determination of specific markers which are useful to differentiate between leukemic cells and normal hematopoiesis in leukemic patients. These markers include leukocyte differentiation antigens, fusion transcripts, transcripts overexpressed by mutated or nonmutated genes, rearranged genes, and individual markers like polymorphic repetitive DNA sequences. The major technologies for MRD detection, their advantages and disadvantages and their clinical applications are discussed in this special issue - from 'bench to bedside'. Providing a comprehensive overview on the significance of MRD in the evaluation, treatment and follow-up of hematologic malignancies, it will be of great value to hematologists, researchers interested in leukemias and lymphomas as well as laboratory technicians.

Measurable residual disease in hematologic malignancies

Author : Francesco Buccisano,Monica L. Guzman,Sara Galimberti
Publisher : Frontiers Media SA
Page : 118 pages
File Size : 55,7 Mb
Release : 2023-06-07
Category : Medical
ISBN : 9782832525388

Get Book

Measurable residual disease in hematologic malignancies by Francesco Buccisano,Monica L. Guzman,Sara Galimberti Pdf

Minimal Residual Disease Testing

Author : Todd E. Druley
Publisher : Springer
Page : 197 pages
File Size : 52,7 Mb
Release : 2018-11-15
Category : Medical
ISBN : 9783319948270

Get Book

Minimal Residual Disease Testing by Todd E. Druley Pdf

This volume provides a concise yet comprehensive overview of minimal residual disease (MRD) testing. The text reviews the history of MRD testing, MRD testing for acute lymphoblastic leukemia/lymphoma, molecular diagnostics for MRD analysis in hematopoietic malignancies, the use of "difference from normal" flow cytometry in monitoring AML response, ML-DS for measurable residual disease detection, and advancements in next generation sequencing for detecting MRD. Written by experts in the field, Minimal Residual Disease Testing: Current Innovations and Future Directions is a valuable resource for hematologists, oncologists, pathologists, and radiologists on the variety of technologies available to detect MRD and how best to integrate these platforms into clinical practice.

Molecular Aspects of Hematologic Malignancies

Author : Michal Witt,Malgorzata Dawidowska,Tomasz Szczepanski
Publisher : Springer Science & Business Media
Page : 468 pages
File Size : 43,7 Mb
Release : 2012-06-30
Category : Science
ISBN : 9783642294679

Get Book

Molecular Aspects of Hematologic Malignancies by Michal Witt,Malgorzata Dawidowska,Tomasz Szczepanski Pdf

This book provides a state-of-the-art approach to the molecular basis of hematologic diseases and its translation into improved diagnostics and novel therapeutic strategies. Several representative hemato-oncologic malignancies are analyzed in detail: acute lymphoblastic leukemia, acute myeloid leukemia, B-cell Non-Hodgkin lymphomas, multiple myeloma, chronic lymphocytic leukemia, chronic myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms. Experts in the field describe the molecular methods applied for modern diagnostics and therapies, such as hematopoietic stem cell transplantation, donor recipient matching, banking of biological material, analyses of post-transplant chimerism, and minimal residual disease monitoring. The volume concludes with an extensive section comprising thorough step-by-step protocols of molecular techniques in hematology, all of them validated in the authors’ own laboratories.

Multiparameter Flow Cytometry in the Diagnosis of Hematologic Malignancies

Author : Anna Porwit,Marie Christine Béné
Publisher : Cambridge University Press
Page : 247 pages
File Size : 55,9 Mb
Release : 2018-01-25
Category : Medical
ISBN : 9781107503830

Get Book

Multiparameter Flow Cytometry in the Diagnosis of Hematologic Malignancies by Anna Porwit,Marie Christine Béné Pdf

This practical manual offers an active understanding of how to implement flow-cytometry when facing complex, haematological diseases.

Leukemia and Lymphoma

Author : Theodore F. Zipf,Dennis A. Johnston
Publisher : Springer Science & Business Media
Page : 355 pages
File Size : 43,7 Mb
Release : 2002-10-21
Category : Medical
ISBN : 9781592593187

Get Book

Leukemia and Lymphoma by Theodore F. Zipf,Dennis A. Johnston Pdf

In Leukemia and Lymphoma: Detection of Minimal Residual Disease, hands-on experts describe and discuss the minimal residual disease (MRD) methods they have successfully pioneered for leukemias and lymphomas. They apply reverse transcription PCR (RT-PCR) to acute myeloid leukemia (AML), chronic myelogenous leukemia (CML), and acute promyelocytic leukemia (APL). Other PCR methods are used for Non-Hodgkin's Lymphoma and for the monitoring of follicular lymphoma. Additional chapters address the use of real-time quantitative PCR (RQ-PCR), the emergent method of choice, in patients with acute lymphoblastic leukemia (ALL), the evaluation of MRD techniques in clinical trials, and the application of flow cytometry techniques.

Hematologic Malignancies: Acute Leukemias

Author : S.H. Faderl,H.M. Kantarjian
Publisher : Springer Science & Business Media
Page : 302 pages
File Size : 47,9 Mb
Release : 2007-11-21
Category : Medical
ISBN : 9783540723042

Get Book

Hematologic Malignancies: Acute Leukemias by S.H. Faderl,H.M. Kantarjian Pdf

Better therapy of acute leukemias depends ultimately on better understanding of the distinction between leukemic and normal progenitor cells. This hugely important new book describes the current knowledge of acute leukemia biology and discusses new classification systems that have arisen as a result of emerging insights into pathogenesis. Estey, Faderl and Kantarjian, who all work at the respected Anderson Cancer Center in Houston, Texas, USA, examine in detail advances in the treatment of particular types of acute leukemia. Their book also covers the management of acute leukemia in general as well as the development of new therapies. This book will be extremely useful to clinicians.

Molecular Aspects of Hematologic Malignancies

Author : Michal Witt,Malgorzata Dawidowska,Tomasz Szczepanski
Publisher : Springer
Page : 0 pages
File Size : 46,6 Mb
Release : 2015-06-26
Category : Science
ISBN : 3642445225

Get Book

Molecular Aspects of Hematologic Malignancies by Michal Witt,Malgorzata Dawidowska,Tomasz Szczepanski Pdf

This book provides a state-of-the-art approach to the molecular basis of hematologic diseases and its translation into improved diagnostics and novel therapeutic strategies. Several representative hemato-oncologic malignancies are analyzed in detail: acute lymphoblastic leukemia, acute myeloid leukemia, B-cell Non-Hodgkin lymphomas, multiple myeloma, chronic lymphocytic leukemia, chronic myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms. Experts in the field describe the molecular methods applied for modern diagnostics and therapies, such as hematopoietic stem cell transplantation, donor recipient matching, banking of biological material, analyses of post-transplant chimerism, and minimal residual disease monitoring. The volume concludes with an extensive section comprising thorough step-by-step protocols of molecular techniques in hematology, all of them validated in the authors’ own laboratories.

Multiple Myeloma and Other Plasma Cell Neoplasms

Author : Meletios A. Dimopoulos,Thierry Facon,Evangelos Terpos
Publisher : Springer
Page : 245 pages
File Size : 49,8 Mb
Release : 2018-02-16
Category : Medical
ISBN : 9783319255866

Get Book

Multiple Myeloma and Other Plasma Cell Neoplasms by Meletios A. Dimopoulos,Thierry Facon,Evangelos Terpos Pdf

This book is a comprehensive source of up-to-date information on plasma cell neoplasms. Key features include the provision of new criteria for the diagnosis of symptomatic multiple myeloma requiring treatment and the description of novel therapies for myeloma and other plasma cell neoplasms that have only very recently been licensed by the U.S. Food and Drug Administration. Examples include lenalidomide as first-line therapy, panobinostat in combination with bortezomib plus dexamethasone for relapsed/refractory myeloma, ibrutinib for Waldenström’s macroglobulinemia, and new therapeutic regimens for systemic amyloidosis and POEMS syndrome. Information is also provided on drug combinations that have shown encouraging results and are very near to approval. Other important aspects covered in the book are the role of different imaging modalities in workup and the significance of newly acquired data relating to prognosis and minimal residual disease. Readers will find Multiple Myeloma and Other Plasma Cell Neoplasms to be a rich source of knowledge that will be invaluable in improving patient management.

Diagnostic and Therapeutic Advances in Hematologic Malignancies

Author : Martin S. Tallman,Leo I. Gordon
Publisher : Springer Science & Business Media
Page : 383 pages
File Size : 51,9 Mb
Release : 2007-11-23
Category : Medical
ISBN : 9780585385716

Get Book

Diagnostic and Therapeutic Advances in Hematologic Malignancies by Martin S. Tallman,Leo I. Gordon Pdf

There is no field of medicine in which advances in therapy have been so closely linked to a better understanding of molecular medicine than in the area of hematologic malignancies. Diagnostic and Therapeutic Advances in Hematologic Malignancies will provide practitioners and academic clinicians with a better understanding of the constant evolving concepts in this area.

Acute Leukemias

Author : Stefan H. Faderl,Hagop M. Kantarjian,Elihu Estey
Publisher : Springer Nature
Page : 283 pages
File Size : 55,7 Mb
Release : 2020-10-10
Category : Medical
ISBN : 9783030536336

Get Book

Acute Leukemias by Stefan H. Faderl,Hagop M. Kantarjian,Elihu Estey Pdf

Better therapy of acute leukemias depends ultimately on better understanding of the distinction between leukemic and normal progenitor cells. This hugely important new book describes the current knowledge of acute leukemia biology and discusses new classification systems that have arisen as a result of emerging insights into pathogenesis. Estey, Faderl and Kantarjian, who all work at the respected Anderson Cancer Center in Houston, Texas, USA, examine in detail advances in the treatment of particular types of acute leukemia. Their book also covers the management of acute leukemia in general as well as the development of new therapies. This book will be extremely useful to clinicians.

Biological Mechanisms of Minimal Residual Disease and Systemic Cancer

Author : Julio A. Aguirre-Ghiso
Publisher : Springer
Page : 162 pages
File Size : 46,5 Mb
Release : 2018-11-08
Category : Medical
ISBN : 9783319977461

Get Book

Biological Mechanisms of Minimal Residual Disease and Systemic Cancer by Julio A. Aguirre-Ghiso Pdf

This book focuses on the biological mechanisms of minimal residual disease (MRD) and recurrence. It integrates this biology in solid cancers and in hematological malignancies. It reports also on technological advancements for monitoring MRD, derived from mechanistic insights. Chapters in solid and hematological malignancies address stem cell biology, genetics, epigenetics and micro-environmental regulation of dormant MRD. Novel insight into technologies for molecular phenotyping of MRD and monitoring of CTCs, DTCs and cell free RNA and DNA are also addressed extensively. Five chapters explore the above concepts in solid cancers such as prostate, breast, melanoma, head and neck and esophageal. Two chapters also explore the basic mechanisms of vascular biology targeting and epigenetic mechanisms regulating pluripotency programs during dormancy. Similar biology is explored in hematological malignancies such as T-ALL, CML, AML and multiple myeloma in additional four chapters. This book is edited and prefaced by Dr. Julio Aguirre-Ghiso, an expert in dormancy and recurrence. The chapters are written by world-recognized experts Drs. Ravi Bahtia, Samir Parekh, Russel Taichman, Monica Guzman, David Hoon, Denis Schewe, Irmela Jeremias, Cyrus Ghajar, Maria Soledad Sosa and Nicholas Stoecklein. The topic of this book is of particular interest to both basic cancer cell biologists and physician scientists that are working to provide a more integrated view of the biology of MRD and to those interested in working on or learning about this paradigm. The integrated and cross-disciplinary focus of the book from biology to medicine seeks to help bridge gaps to improve cancer care and prevent recurrences.

Immunoconjugate Therapy of Hematologic Malignancies

Author : Steven T. Rosen,Timothy M. Kuzel
Publisher : Springer Science & Business Media
Page : 293 pages
File Size : 43,7 Mb
Release : 2012-12-06
Category : Medical
ISBN : 9781461530763

Get Book

Immunoconjugate Therapy of Hematologic Malignancies by Steven T. Rosen,Timothy M. Kuzel Pdf

The hybridoma technique for producing monoclonal antibodies, developed by Drs. Kohler and Millstein in 1975, revolutionized the field of tumor immunology. It is now clear that there are antigens associated with or restricted to human neoplasms that have biologic significance. Monoclonal antibodies have already been demonstrated to have great immunodiagnostic value and it is anticipated that they will become a component of our therapeutic armamentarium. Most investigators in the field, however, feel that the true potential of monoclonal antibodies in cancer therapy remains to be determined. Clearly the most encouraging results have been witnessed in the treatment of hematologic malignancies. This volume of CANCER TREATMENT AND RESEARCH explores the current state of the art of immunoconjugate therapy of hematologic malignancies. Immunoconjugate Therapy of Hematologic Malignancies provides an update of a rapidly advancing field. The preliminary experience of a number of investigators suggests a role for targeted therapy in the treatment of hematologic malignancies. At the present time, immunoconjugates have, in most instances, been reserved for patients with advanced refractory disease. However, it is anticipated in the future that these reagents will be utilized as a complement to traditional therapy or as post-remission consolidation in patients with minimal residual disease. The obstacles have been defined; solutions will require further research and creative imagination.

Minimal Residual Disease in Acute Leukemia 1986

Author : A. Hagenbeek,B. Löwenberg
Publisher : Springer Science & Business Media
Page : 407 pages
File Size : 46,8 Mb
Release : 2012-12-06
Category : Medical
ISBN : 9789400942738

Get Book

Minimal Residual Disease in Acute Leukemia 1986 by A. Hagenbeek,B. Löwenberg Pdf

Relapse of leukemia following successful remission-induction therapy remains a major obstacle in the treatment of patients with acute leukemia. Leukemia recurs most frequently in patients with acute myeloblastic leukemia (AML) and high risk acute lymphoblastic leukemia (ALL) following chemotherapy and less often in patients with low risk ALL and particularly in patient groups> submitted to allogeneic marrow transplantation. ' It is likely that the great majority of these recurrences originate from residual leukemic cells that survive initial remission-induction chemotherapy. Today, several research groups throughout the world place emphasis on studies concerned with the detection and treatment of 'minimal residual disease' (MRD). These investigations are conducted with the common objective to tackle the remaining cells. 'Minimal Residual Disease in Acute Leukemia: 1986' summarizes the fast advancements in this area. Several disciplines are concerned with the analysis of leukemic cells. The perspectives of cytogenetic and molecular genetic approaches for applica tion in the detection of MRD are reviewed. In this respect, modern cyto genetics provide highly specific tumor markers. The resolution of cyto genetic methods can be particularly improved when combined with other techniques which select relevant subpopulations of cells. Characterization of oncogenes and gene rearrangements, including those of immunoglobulin and T-cell receptor genes, and the measurement of gene products, have been established. Techniques based on these approaches offer interesting tools for the detection of MRD. New possibilities of employing monoclonal anti bodies are also presented.

Rare Hematological Malignancies

Author : Stephen M. Ansell
Publisher : Springer Science & Business Media
Page : 435 pages
File Size : 44,7 Mb
Release : 2007-11-17
Category : Medical
ISBN : 9780387737447

Get Book

Rare Hematological Malignancies by Stephen M. Ansell Pdf

This hugely practical work will be a bible in the pocket of hematologists and other practitioners everywhere, covering as it does malignant hematologic diseases that physicians will only occasionally see. It provides accurate, up-to-date information on the disease biology as well as practical recommendations concerning disease management. Information concerning these diseases, and particularly regarding their management, can be extremely difficult to find. Not any more.